Abstract
Using the yeast one-hybrid approach to screen a human breast tissue hybrid cDNA expression library, we have found that four orphan/nuclear receptors, ERRα-1, EAR-2, COUP-TFI (EAR-3), and RARγ, bind to the silencer (S1) region of the human aromatase gene. S1 down regulates promoters I.3 and II of the human aromatase gene. In this study, the interaction of EAR-2, COUP-TFI, and RARγ with S1 was confirmed by DNA mobility shift analysis. In contrast to the findings that ERRα-1 behaves as a positive regulatory factor, these three nuclear receptors were found, by mammalian cell transfection experiments, to act as negative regulatory factors by binding to S1. Furthermore, the negative action of these three nuclear receptors could override the positive effect of ERRα-1. RT–PCR analysis of 11 cell lines and 55 human breast tumor specimens has shown that these nuclear receptors are expressed in human breast tissue. Since EAR-2, COUP-TFI, and RARγ are expressed at high levels, it is likely that S1 is a negative regulatory element that suppresses aromatase promoters I.3 and II in normal breast tissue. In cancer tissue, S1 may function as a positive element since ERRα-1 is expressed, but EAR-2 and RARγ are only present in a small number of tumor specimens. This hypothesis is sustained by the finding that there is a weak inverse correlation between the expression of COUP-TFI and that of aromatase in breast tumor tissue. Our studies have revealed that estrogen receptor alpha (ERα) can also bind to S1, in a ligand-dependent manner. By binding to S1, ERα down-regulates the aromatase promoter activity. These results demonstrate that nuclear receptors play important roles in modulating aromatase expression in human breast tissue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bonnelye E, Vanacker JM, Dittmar T, Begue A, Desbiens X, Denhardt DT, Aubin JE, Laudet V, Fournier B . 1997 Mol. Endocrinol. 11: 905–916
Bulun SE, Noble LS, Takayama K, Michael MD, Agarwal V, Fisher C, Zhao Y, Hinshelwood MM, Ito Y, Simpson ER . 1997 J. Steroid. Biochem. Mol. Biol. 61: 133–139
Chomczymski P . 1998 Current protocols in molecular biology vol 1 4.2.1–4.2.2
Chu K, Zingg HH . 1998 Mol. Cell Endocrinol. 137: 145–154
Dotzlaw H, Leygue E, Watson P, Murphy LC . 1999 Clin. Cancer Res. 5: 2103–2107
Harada N . 1993 Biochem. Biophys. Res. Commun. 189: 1001–1007
Harada N . 1997 J. Steroid Biochem. Mol. Biol. 61: 175–184
Harada N, Utsumi T, Takagi Y . 1993 Proc. Natl. Acad. Sci. USA 90: 11312–11316
Johnston S, Liu X, Zuo F, Eisenbraun TL, Wiley SR, Kraus RJ, Mertz JE . 1997 Mol. Endocrinol. 11: 342–352
Kao YC, Cam LL, Laughton CA, Zhou D, Chen S . 1996 Cancer Res. 56: 3451–3460
Klinge CM, Silver BF, Driscoll MD, Sathya G, Bambara RA, Hilf R . 1997 J. Biol. Chem. 272: 31465–31474
Lazennec G, Kern L, Valotaire Y, Sallbert G . 1997 Mol. Cell Biol. 17: 5053–5066
Mahendroo MS, Means GD, Mendelson CR, Simpson ER . 1991 J. Biol. Chem. 266: 11276–11280
Mahendroo MS, Mendelson CR, Simpson ER . 1993 J. Biol. Chem. 268: 19463–19470
Means GD, Kilgore MW, Mahendroo MS, Mendelson CR, Simpson ER . 1991 Mol. Endocrinol. 5: 2005–2013
Nakamura J, Lu Q, Aberdeen G, Albrecht E, Brodie A . 1999 J. Clin. Endocrinol. Metab. 84: 1432–1437
Nakshatri H, Bhat-Nakshatri . 1998 Nucleic Acids Res. 26: 2491–2499
Rosenthal N . 1987 Methods Enzymol. 152: 705–720
Seed B, Sheen JY . 1988 Gene 67: 271–277
Segel IH . 1976 Biological Calculations 2nd edition John Wiley & Sons, Inc. pp 218–
Singh H, Sen R, Baltimore D, Sharp PA . 1986 Nature 319: 154–158
Sladek R, Bader JA, Giguere V . 1997 Mol. Cell Biol. 17: 5400–5409
Thompson Jr JA, Siiteri PK . 1974 J. Biol. Chem. 249: 5364–5372
Tran P, Zhang XK, Salbert G, Hermann T, Lehmann JM,, Pfahl M . 1992 Mol. Cell Biol. 12: 4666–4676
Vanacker JM, Pettersson K, Gustafsson JA, Laudet V . 1999 EMBO J. 18: 4270–4279
Vorgia P, Zannis VI, Kardassis D . 1998 J. Biol. Chem. 273: 4188–4196
Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG . 1997 Cancer Res. 57: 4158–4161
Yang C, Chen S . 1999 Cancer Res. 59: 4519–4524
Yang C, Zhou D, Chen S . 1998 Cancer Res. 58: 5695–5700
Zeitoun K, Takayama K, Michael MD, Bulun SE . 1999 Mol. Endocrinol. 13: 239–253
Zho F, Mertz RJ . 1995 Proc. Natl. Acad. Sci. USA 9: 2 8586–8590
Zhou C, Zhou D, Esteban J, Murai J, Sitteri PI, Wilczynski S, Chen S . 1996 J. Steroid Biochem. Mol. Biol. 59: 163–171
Zhou D, Chen S . 1998 Arch. Biochem. Biophys. 353: 213–220
Zhou D, Chen S . 1999 Arch. Biochem. Biophys. 371: 179–190
Zhou D, Quach KM, Yang C, Lee SY, Pohajdak B, Chen S . 2000 Mol. Endocrinol. 14: 986–998
Zhou D, Wang J, Chen E, Murai J, Siiteri PK, Chen S . 1993 J. Steroid Biochem. Mol. Biol. 46: 147–153
Acknowledgements
This research was supported by the National Institutes of Health Grants CA44735, ES08258 and CA65767.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, C., Yu, B., Zhou, D. et al. Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene 21, 2854–2863 (2002). https://doi.org/10.1038/sj.onc.1205386
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205386
Keywords
This article is cited by
-
Common variants at 19p13 are associated with susceptibility to ovarian cancer
Nature Genetics (2010)
-
Aromatase inhibitors: from bench to bedside and back
Breast Cancer (2008)